PK And Safety Study Of PF-04171327 In Healthy Japanese And Western Subjects In Fasting And Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Healthy
Interventions
DRUG

PF-04171327

Oral single 5 mg dose as one 5 mg tablet

DRUG

PF-04171327

Oral single 10 mg dose as one 10 mg tablet

DRUG

PF-04171327

Oral single 30 mg dose as three 10 mg tablets

DRUG

Placebo

Oral single dose as matching placebo

DRUG

PF-04171327

Oral multiple 20 mg doses as two 10 mg tablets for 12 days

DRUG

Placebo

Oral multiple doses as matching placebo for 12 days

Trial Locations (1)

91206

Pfizer Investigational Site, Glendale

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01362673 - PK And Safety Study Of PF-04171327 In Healthy Japanese And Western Subjects In Fasting And Fed Conditions | Biotech Hunter | Biotech Hunter